These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8205939)

  • 1. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey.
    Danisovicová A; Brezina M; Belan S; Kayserová H; Kaiserová E; Hruskovic I; Orosová K; Dluholucký S; Galova K; Mathéova E
    Chemotherapy; 1994; 40(3):209-14. PubMed ID: 8205939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.
    Schaad UB; Stoupis C; Wedgwood J; Tschaeppeler H; Vock P
    Pediatr Infect Dis J; 1991 Oct; 10(10):723-9. PubMed ID: 1945573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
    Linseman DA; Hampton LA; Branstetter DG
    Fundam Appl Toxicol; 1995 Nov; 28(1):59-64. PubMed ID: 8566484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
    Postnikov SS
    Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient.
    Samuelson WM; Pleasants RA; Whitaker MS
    Ann Pharmacother; 1993 Mar; 27(3):302-3. PubMed ID: 8453165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis].
    Milio MC; Campana S
    Pediatr Med Chir; 1995; 17(1):53-5. PubMed ID: 7739928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
    Postnikov SS; Semykin SIu; Nazhimov VP; Novichkova GA
    Antibiot Khimioter; 2002; 47(9):14-7. PubMed ID: 12619515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential quinolone-induced cartilage toxicity in children.
    Camp KA; Miyagi SL; Schroeder DJ
    Ann Pharmacother; 1994 Mar; 28(3):336-8. PubMed ID: 8193422
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.
    Förster C; Schwabe R; Lozo E; Zippel U; Vormann J; Günther T; Merker HJ; Stahlmann R
    Arch Toxicol; 1997; 72(1):26-32. PubMed ID: 9458187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats.
    Kappel EM; Shakibaei M; Bello A; Stahlmann R
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3320-2. PubMed ID: 12234871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative morphological analysis of the articular cartilage, epiphyseal plate, spongy bone, and synovial membrane of the knee joint in children treated and not treated with ciprofloxacin].
    Postnikov SS; Nazhimov VP; Semykin SIu; Kapranov NI
    Antibiot Khimioter; 2000; 45(11):9-13. PubMed ID: 11210306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis and drug-induced arthropathy.
    Jawad AS
    Br J Rheumatol; 1989 Apr; 28(2):179-80. PubMed ID: 2706427
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy.
    Stahlmann R; Förster C; Shakibaei M; Vormann J; Günther T; Merker HJ
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2013-8. PubMed ID: 8540708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolone arthropathy--acute toxicity to immature articular cartilage.
    Gough AW; Kasali OB; Sigler RE; Baragi V
    Toxicol Pathol; 1992; 20(3 Pt 1):436-49; discussion 449-50. PubMed ID: 1295072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.
    Alfaham M; Holt ME; Goodchild MC
    Br Med J (Clin Res Ed); 1987 Sep; 295(6600):699. PubMed ID: 3117310
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis of quinolone-induced arthropathy in juvenile dogs by use of magnetic resonance (MR) imaging.
    Yabe K; Yoshida K; Yamamoto N; Nishida S; Ohshima C; Sekiguchi M; Yamada K; Furuhama K
    J Vet Med Sci; 1997 Jul; 59(7):597-9. PubMed ID: 9271457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones.
    Warren RW
    Pediatr Infect Dis J; 1997 Jan; 16(1):118-22; discussion 123-6. PubMed ID: 9002121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early pathophysiologic feature of arthropathy in juvenile dogs induced by ofloxacin, a quinolone antimicrobial agent.
    Yabe K; Satoh H; Ishii Y; Jindo T; Sugawara T; Furuhama K; Goryo M; Okada K
    Vet Pathol; 2004 Nov; 41(6):673-81. PubMed ID: 15557076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on articular and general toxicity of orally administered ozenoxacin in juvenile rats and dogs.
    González Borroto JI; Awori MS; Chouinard L; Smith SY; Tarragó C; Blazquez T; Gargallo-Viola D; Zsolt I
    Future Microbiol; 2018 May; 13():31-40. PubMed ID: 29745239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the new quinolones in pediatrics.
    Schaad UB
    Isr J Med Sci; 1994; 30(5-6):463-8. PubMed ID: 8034505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.